COVID-19 Neurologic Complications: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 22: Line 22:
***Dehydration
***Dehydration
***Hypoxia
***Hypoxia
****
 
[[File:Photo 2020-06-24 15-35-07.jpg|500px|none|thumb|By {{Fs}} / https://en.wikipedia.org/wiki/File:Migraine.jpg]]
 
*'''Natural history'''
*'''Natural history'''
*'''Sign and symptoms'''
*'''Sign and symptoms'''

Revision as of 20:03, 24 June 2020

To go to the COVID-19 project topics list, click here.

COVID-19 Microchapters

Home

Long COVID

Frequently Asked Outpatient Questions

Frequently Asked Inpatient Questions

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating COVID-19 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Vaccines

Secondary Prevention

Future or Investigational Therapies

Ongoing Clinical Trials

Case Studies

Case #1

COVID-19 Neurologic Complications On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of COVID-19 Neurologic Complications

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on COVID-19 Neurologic Complications

CDC on COVID-19 Neurologic Complications

COVID-19 Neurologic Complications in the news

Blogs on COVID-19 Neurologic Complications

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for COVID-19 Neurologic Complications

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D., Rinky Agnes Botleroo, M.B.B.S.

Overview

Pathophysiology of the Complications in the Nervous System

Mechanism of targetting the Nervous System

Complications in the Central Nervous System

Headache

  • Pathophysiology
    • The exact pathogenesis of headache in COVID 19 patients is not fully understood.
    • It is thought that headache is the result of:
      • Cytokine release
      • Direct invasion
      • Metabolic disturbances
      • Inflammation
      • Dehydration
      • Hypoxia
By Fahimeh Shojaei, M.D. / https://en.wikipedia.org/wiki/File:Migraine.jpg
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Cerebrovascular Accident/Stroke

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Acute Encephalitis

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Viral Meningitis

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Epileptic Seizures

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Encephalopathy

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Complications in the Peripheral Nervous system

Guillain-Barre syndrome

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Anosmia

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Acute Myelitis

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Miller Fischer Sydrome

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Polyneuritis Cranialis

  • Pathophysiology
  • Natural history
  • Sign and symptoms
  • Diagnosis
  • Treatment

Complications due to medication interaction

1. Statin induced myotoxicity

  • Myalgia, myopathies, rhabdomyolysis

2. 2nd and 3rd degree atrioventricular block

  • Lopinavir/ Ritonavir (Kaltera) (400 mg/100 mg)

3. Prolong QTc interval

  • Chloroquine/Hydroxychloroquine

4. Myelotoxicity

  • Ribavirin

5. Prolonged PR interval

  • Atazanavir

6. Myelosuppression

7.

References